Decheng Capital LLC
MENLO PARK, CA · CIK 2010850 · 13F filing filed 2026-08-14
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyAtherton, CA
$731.7m
reported value
+10.7% vs Q1 2026
14positions
98.1%in top 10
1 new
0 added
3 reduced
1 sold out
vs Q1 2026
Holdings, Q2 2026
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| CG ONCOLOGY INC CGON | $452.7m61.87% | Unchanged |
| NUVATION BIO INC NUVB | $147.4m20.15% | Unchanged |
| AARDVARK THERAPEUTICS INC AARD | $22.6m3.08% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $21.4m2.92% | Unchanged |
| UPSTREAM BIO INC UPB | $18.9m2.58% | Unchanged |
| ARCUS BIOSCIENCES INC RCUS | $14.3m1.96% | Reduced -13.0k |
| EQUILLIUM INC EQ | $14.2m1.94% | Unchanged |
| REVOLUTION MEDICINES INC RVMD | $9.9m1.35% | Reduced -40.8k |
| LYELL IMMUNOPHARMA INC COM | $9.7m1.33% | Unchanged |
| BEYONDSPRING INC BYSI | $6.7m0.91% | Unchanged |
| ZENTALIS PHARMACEUTICALS INC ZNTL | $6.4m0.88% | Unchanged |
| NEWAMSTERDAM PHARMA COMPANY NAMS | $6.0m0.82% | Reduced -148.2k |
| PYXIS ONCOLOGY INC PYXS | $983.7k0.13% | Unchanged |
| TANGO THERAPEUTICS INC TNGX | $625.2k0.09% | New |
Sold out since Q1 2026
| Security | Value then |
|---|---|
| KRYSTAL BIOTECH INC KRYS | $1.9m7.3k shares |